Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

1.

Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.

Faith SA, Wu Y, Kuhrt D, Steckbeck JD, Craigo JK, Clements JE, Cole KS.

Virology. 2010 Apr 25;400(1):86-92. doi: 10.1016/j.virol.2010.01.014. Epub 2010 Feb 11.

PMID:
20153009
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.

Cole KS, Alvarez M, Elliott DH, Lam H, Martin E, Chau T, Micken K, Rowles JL, Clements JE, Murphey-Corb M, Montelaro RC, Robinson JE.

Virology. 2001 Nov 10;290(1):59-73.

PMID:
11883006
[PubMed - indexed for MEDLINE]
3.

Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.

Johnson WE, Sanford H, Schwall L, Burton DR, Parren PW, Robinson JE, Desrosiers RC.

J Virol. 2003 Sep;77(18):9993-10003.

PMID:
12941910
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Simian immunodeficiency virus mutants resistant to serum neutralization arise during persistent infection of rhesus monkeys.

Burns DP, Collignon C, Desrosiers RC.

J Virol. 1993 Jul;67(7):4104-13.

PMID:
8510218
[PubMed - indexed for MEDLINE]
Free PMC Article
6.
7.

Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.

Meyer D, Anderson DE, Gardner MB, Torres JV.

AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):751-60.

PMID:
9643375
[PubMed - indexed for MEDLINE]
8.

An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.

Torres JV, Malley A, Banapour B, Anderson DE, Axthelm MK, Gardner MB, Benjamini E.

AIDS Res Hum Retroviruses. 1993 May;9(5):423-30.

PMID:
7686386
[PubMed - indexed for MEDLINE]
9.

Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251.

Matsumi S, Matsushita S, Yoshimura K, Javaherian K, Takatsuki K.

AIDS Res Hum Retroviruses. 1995 Apr;11(4):501-8.

PMID:
7632464
[PubMed - indexed for MEDLINE]
10.

Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.

Steckbeck JD, Orlov I, Chow A, Grieser H, Miller K, Bruno J, Robinson JE, Montelaro RC, Cole KS.

J Virol. 2005 Oct;79(19):12311-20.

PMID:
16160158
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antigenic variation of SIV: mutations in V4 alter the neutralization profile.

Kinsey NE, Anderson MG, Unangst TJ, Joag SV, Narayan O, Zink MC, Clements JE.

Virology. 1996 Jul 1;221(1):14-21.

PMID:
8661410
[PubMed - indexed for MEDLINE]
Free Article
12.

Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.

Clements JE, Montelaro RC, Zink MC, Amedee AM, Miller S, Trichel AM, Jagerski B, Hauer D, Martin LN, Bohm RP, et al.

J Virol. 1995 May;69(5):2737-44.

PMID:
7707496
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.

Silvera P, Flanagan B, Kent K, Rud E, Powell C, Corcoran T, Bruck C, Thiriart C, Haigwood NL, Stott EJ.

AIDS Res Hum Retroviruses. 1994 Oct;10(10):1295-304.

PMID:
7848685
[PubMed - indexed for MEDLINE]
14.

Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.

Kuwata T, Takaki K, Yoshimura K, Enomoto I, Wu F, Ourmanov I, Hirsch VM, Yokoyama M, Sato H, Matsushita S.

J Virol. 2013 May;87(10):5424-36. doi: 10.1128/JVI.00201-13. Epub 2013 Mar 6.

PMID:
23468483
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.

Postler TS, Martinez-Navio JM, Yuste E, Desrosiers RC.

J Virol. 2012 Jan;86(2):1145-57. doi: 10.1128/JVI.06463-11. Epub 2011 Nov 9.

PMID:
22072749
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.

Kodama T, Burns DP, Silva DP, Veronese FD, Desrosiers RC.

J Virol. 1991 Apr;65(4):2010-8.

PMID:
1705994
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.

Steckbeck JD, Grieser HJ, Sturgeon T, Taber R, Chow A, Bruno J, Murphy-Corb M, Montelaro RC, Cole KS.

J Med Primatol. 2006 Aug;35(4-5):248-60.

PMID:
16872288
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.

Liang X, Casimiro DR, Schleif WA, Wang F, Davies ME, Zhang ZQ, Fu TM, Finnefrock AC, Handt L, Citron MP, Heidecker G, Tang A, Chen M, Wilson KA, Gabryelski L, McElhaugh M, Carella A, Moyer C, Huang L, Vitelli S, Patel D, Lin J, Emini EA, Shiver JW.

J Virol. 2005 Oct;79(19):12321-31.

PMID:
16160159
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.

Lopker M, Easlick J, Sterrett S, Decker JM, Barbian H, Learn G, Keele BF, Robinson JE, Li H, Hahn BH, Shaw GM, Bar KJ.

J Virol. 2013 May;87(10):5477-92. doi: 10.1128/JVI.03419-12. Epub 2013 Mar 6.

PMID:
23468494
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk